Evaluate NACA and diNACA in Preventing Oxidative Stress-Induced Cataract Formation: Ex Vivo Study

StatusActive
Effective start/end date7/10/196/10/20

Funding

  • Nacuity Pharmaceuticals, Inc.: $10,895.00

Keywords

  • Vision Research